![PDF] Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d5dc7b2815d18f1914a33d934cfc5dbfe8d4f767/3-Figure1-1.png "PDF] Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis | Semantic Scholar")
PDF] Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis | Semantic Scholar
PDF) Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer
Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells | PLOS ONE
CD44 as a tumor biomarker and therapeutic target | Experimental Hematology & Oncology | Full Text
The Prognostic Role of Cancer Stem Cell Markers for Long-term Outcome After Resection of Colonic Liver Metastases | Anticancer Research
Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases
Expression of CD44 and CD133 in normal colonic tissues and colorectal... | Download Scientific Diagram
Frontiers | Breast Cancer Classification Based on Tumor Budding and Stem Cell-Related Signatures Facilitate Prognosis Evaluation
Combined CD133/CD44 Expression as a Prognostic Indicator of Disease-Free Survival in Patients With Colorectal Cancer
Prognostic impact of CD44-positive cancer stem-like cells at the invasive front of gastric cancer | British Journal of Cancer
Prognostic value of CD44 expression in renal cell carcinoma: a systematic review and meta-analysis | Scientific Reports
CD44v6 Is a Marker of Constitutive and Reprogrammed Cancer Stem Cells Driving Colon Cancer Metastasis - ScienceDirect
![PDF] Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2ba686ab0a76882b432cd1658b37f2825fa4281e/3-Figure1-1.png "PDF] Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients | Semantic Scholar")
PDF] Immunohistochemical Detection of Cancer Stem Cell Related Markers CD44 and CD133 in Metastatic Colorectal Cancer Patients | Semantic Scholar
PDF) The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-AnalysisImage_1.TIFImage_10.TIFImage_11.TIFImage_12.TIFImage_13.TIFFImage_14.tifImage_15.tifImage_2.TIFImage_3.TIFImage_4.TIFImage_5.TIFImage_6.TIFImage_7.TIFImage_8.TIFImage_9 ...
Sequential expression of putative stem cell markers in gastric carcinogenesis | British Journal of Cancer
![PDF] Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/f49fe3fc83be03d1d479241493fc25c51d3dd7ee/4-Figure1-1.png "PDF] Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer | Semantic Scholar")
PDF] Co-expression and prognostic significance of putative CSC markers CD44, CD133, wild-type EGFR and EGFRvIII in metastatic colorectal cancer | Semantic Scholar
PDF) Prognostic significance of CD44 variant 2 upregulation in colorectal cancer
Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells | PLOS ONE
Expression of the Cancer Stem Cell Markers CD44 and CD133 in Colorectal Cancer: An Immunohistochemical Staining Analysis
Biomolecules | Free Full-Text | CD44: A Multifunctional Mediator of Cancer Progression | HTML
CD44-high neural crest stem-like cells are associated with tumour aggressiveness and poor survival in neuroblastoma tumours - eBioMedicine
Evaluation of the role of CD44 as a cancer stem cell marker in colorectal carcinoma: immunohistochemical study Holah NS, Aiad HA, Asaad NY, Elkhouly EA, Lasheen AG - Menoufia Med J
CD44 as a tumor biomarker and therapeutic target | Experimental Hematology & Oncology | Full Text
